Acrinova AB Series B (ST:ACRI-B) — Market Cap & Net Worth
Market Cap & Net Worth: Acrinova AB Series B (ACRI-B)
Acrinova AB Series B (ST:ACRI-B) has a market capitalization of $21.71 Million (Skr201.77 Million) as of September 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #24934 globally and #494 in its home market, demonstrating a -8.05% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Acrinova AB Series B's stock price Skr7.08 by its total outstanding shares 28498131 (28.50 Million). Also see Acrinova AB Series B (ACRI-B) total assets for a full breakdown of the balance sheet.
Acrinova AB Series B Market Cap History: 2021 to 2026
Acrinova AB Series B's market capitalization history from 2021 to 2026. Data shows change from $33.15 Million to $21.71 Million (-6.37% CAGR). Also see Acrinova AB Series B cash flow conversion for how efficiently the company converts equity into cash flow.
Acrinova AB Series B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Acrinova AB Series B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Acrinova AB Series B (ACRI-B) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.25x
Acrinova AB Series B's market cap is 0.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.54x
Acrinova AB Series B's market cap is 0.54 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $33.15 Million | $101.95 Million | $153.16 Million | 0.33x | 0.22x |
| 2022 | $21.93 Million | $130.53 Million | $79.34 Million | 0.17x | 0.28x |
| 2023 | $24.42 Million | $147.08 Million | $7.76 Million | 0.17x | 3.15x |
| 2024 | $28.09 Million | $159.70 Million | $35.91 Million | 0.18x | 0.78x |
| 2025 | $32.20 Million | $128.15 Million | $59.97 Million | 0.25x | 0.54x |
Competitor Companies of ACRI-B by Market Capitalization
Companies near Acrinova AB Series B in the global market cap rankings as of September 19, 2026. Review tangible equity quality of Acrinova AB Series B to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Acrinova AB Series B by market ranking:
- Swiss Prime Site AG (SW:SPSN): Ranked #2222 globally with a market cap of $10.13 Billion USD ( CHF8.01 Billion CHF).
- Central Pattana Public Company Limited (BK:CPN-R): Ranked #2435 globally with a market cap of $8.99 Billion USD ( ฿288.35 Billion THB).
- Central Pattana Public Company Limited (BK:CPN): Ranked #2434 globally with a market cap of $8.99 Billion USD ( ฿288.35 Billion THB).
- The Phoenix Mills Limited (NSE:PHOENIXLTD): Ranked #2829 globally with a market cap of $7.26 Billion USD ( Rs671.61 Billion INR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2222 | Swiss Prime Site AG | SW:SPSN | $10.13 Billion | CHF125.80 |
| #2435 | Central Pattana Public Company Limited | BK:CPN-R | $8.99 Billion | ฿64.25 |
| #2434 | Central Pattana Public Company Limited | BK:CPN | $8.99 Billion | ฿64.25 |
| #2829 | The Phoenix Mills Limited | NSE:PHOENIXLTD | $7.26 Billion | Rs1877.90 |
Acrinova AB Series B Historical Marketcap From 2021 to 2026
Between 2021 and today, Acrinova AB Series B's market cap moved from $33.15 Million to $ 21.71 Million, with a yearly change of -6.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr21.71 Million | -32.57% |
| 2025 | Skr32.20 Million | +14.63% |
| 2024 | Skr28.09 Million | +15.04% |
| 2023 | Skr24.42 Million | +11.37% |
| 2022 | Skr21.93 Million | -33.87% |
| 2021 | Skr33.15 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Acrinova AB Series B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.71 Million USD |
| MoneyControl | $21.71 Million USD |
| MarketWatch | $21.71 Million USD |
| marketcap.company | $21.71 Million USD |
| Reuters | $21.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Acrinova AB Series B
Acrinova AB (publ), a real estate company, owns, develops, and manages real estate properties in Sweden. Its property portfolio includes trade and service, warehouse and production, and residential properties, as well as logistics/production, housing, shop, industrial and commercial premises, restaurant, and office. The company was incorporated in 2014 and is headquartered in Malmö, Sweden.